Company registration number 14020495 (England and Wales)
JAY MEDICAMENTS LTD
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
JAY MEDICAMENTS LTD
CONTENTS
Page
Director's report
1
Balance sheet
2
Statement of changes in equity
Notes to the financial statements
3
JAY MEDICAMENTS LTD
DIRECTOR'S REPORT
FOR THE YEAR ENDED 30 APRIL 2024
- 1 -
The director presents his annual report and financial statements for the year ended 30 April 2024.
Principal activities
The principal activity of the company continued to be that of Special Medical practice activities
Director
The director who held office during the year and up to the date of signature of the financial statements was as follows:
Dr Sanjay Kumar Chugh
(Appointed 1 May 2023)
Small companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
On behalf of the board
Dr Sanjay Kumar Chugh
Director
3 April 2025
JAY MEDICAMENTS LTD
BALANCE SHEET
AS AT
30 APRIL 2024
30 April 2024
- 2 -
30 April 2024
31 March 2023
Notes
£
£
£
£
Fixed assets
Tangible assets
370
493
Investments
121,000
121,370
493
Current assets
Cash at bank and in hand
98,763
157,928
Creditors: amounts falling due within one year
(43,085)
(38,250)
Net current assets
55,678
119,678
Net assets
177,048
120,171
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
177,047
120,170
Total equity
177,048
120,171
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and signed by the director and authorised for issue on 3 April 2025
Dr Sanjay Kumar Chugh
Director
Company registration number 14020495 (England and Wales)
JAY MEDICAMENTS LTD
BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2024
30 April 2024
- 3 -
1
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
-